Maite G. Barrena-Fernandez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

Unveiling the role of age in MASLD development and biological process activation: Implications for translational research.

Unveiling the role of age in MASLD development and biological process activation: Implications for translational research.

Journal: Journal of physiology and biochemistry

Published: May 14, 2026

Ultra-low-pass whole-genome sequencing of bile cfDNA in patients with biliary strictures.

Ultra-low-pass whole-genome sequencing of bile cfDNA in patients with biliary strictures.

Journal: eGastroenterology

Published: March 25, 2026

A guide for establishing patient-derived organoids from bile samples obtained during endoscopic procedures and performing gene expression knockdown.

A guide for establishing patient-derived organoids from bile samples obtained during endoscopic procedures and performing gene expression knockdown.

Journal: Frontiers in cell and developmental biology

Published: February 16, 2026

Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma.

Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma.

Journal: Frontiers in cell and developmental biology

Published: December 11, 2025

Epigenetic drug control of Clec4g/LSECtin expression reduces fibrosis burden in cirrhosis.

Epigenetic drug control of Clec4g/LSECtin expression reduces fibrosis burden in cirrhosis.

Journal: Hepatology communications

Published: November 08, 2025

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 27, 2025

Demonstration of SLU7 as a new cancer target.

Demonstration of SLU7 as a new cancer target.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 19, 2025

Aspartyl-tRNA synthetase 1 (DARS1) reshapes hepatocellular carcinoma proteome and promotes aggressiveness through noncanonical SAGA-MYC signaling modulation.

Aspartyl-tRNA synthetase 1 (DARS1) reshapes hepatocellular carcinoma proteome and promotes aggressiveness through noncanonical SAGA-MYC signaling modulation.

Journal: Hepatology (Baltimore, Md.)

Published: September 10, 2025

Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.

Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.

Journal: Cell reports. Medicine

Published: July 27, 2025

YAP/TAZ-driven cell competition in early MASLD as a tumor-suppressive mechanism.

YAP/TAZ-driven cell competition in early MASLD as a tumor-suppressive mechanism.

Journal: Journal of hepatology

Published: July 05, 2025

Epigenetic mechanisms in HCC immune landscape: Therapeutic implications.

Epigenetic mechanisms in HCC immune landscape: Therapeutic implications.

Journal: Seminars in immunology

Published: June 11, 2025

NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.

NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.

Journal: Hepatology (Baltimore, Md.)

Published: April 03, 2025

Showing 1-12 of 91

Last Updated: 09/26/2026